FENC
Fennec Pharmaceuticals Inc
10.60$
+2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.8% | 95.0% | 90.7% | 13.0% | 51.9% | 47.1% | 35.5% | 96.2% | 93.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.1% | 100.0% | 99.9% | 99.2% | 100.0% | 98.2% | 95.0% | |
| 17.3% | 89.4% | 3.0% | 8.4% | 32.8% | 42.1% | 34.2% | 93.9% | 88.3% | 82.2% | 99.2% | 99.0% | 97.4% | 94.9% | 97.3% | 92.4% | 98.8% | 99.5% | 99.3% | 96.5% | 96.6% | 94.1% | 88.3% | 49.4% | 59.3% | 52.4% | |
| 17.3% | 89.4% | 81.8% | 8.4% | 49.8% | 46.2% | 34.2% | 93.9% | 88.3% | 82.2% | 99.2% | 99.0% | 97.4% | 94.9% | 97.3% | 92.4% | 98.8% | 99.5% | 99.3% | 96.5% | 96.6% | 94.1% | 88.3% | 49.4% | 59.3% | 52.4% | |
| 4.6% | 1.3% | 2.0% | 0.1% | 0.6% | 0.5% | 0.6% | 1.1% | 2.3% | 8.3% | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 5.7% | 32.8% | 28.7% | 33.1% | |
| 0.0% | 0.0% | 3.7% | 1.3% | 0.4% | 0.2% | 0.6% | 1.1% | 2.0% | 9.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | 2.1% | 8.0% | 2.4% | 2.2% | |
| 32.2% | 5.0% | 9.3% | 1.9% | 1.0% | 1.3% | 1.8% | 1.7% | 2.2% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 84.6% | 47.0% | 49.8% | 60.0% | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 92.7% | 6.1% | 10.8% | 40.3% | 20.9% | 29.5% | 54.3% | 17.8% | 49.6% | 51.3% | 182.2% | 102.2% | 309.6% | 183.0% | 74.2% | 46.2% | 10.1% | 5.8% | 7.1% | 16.1% | 7.5% | 29.6% | 109.5% | 143.3% | 113.1% | 50.0% | |
| 74.6% | 5.0% | 10.2% | 4.2% | 3.5% | 9.4% | 28.3% | 14.0% | 40.1% | 50.4% | 182.2% | 102.2% | 309.6% | 183.0% | 74.2% | 46.2% | 10.1% | 5.8% | 7.1% | 16.1% | 7.5% | 7.4% | 17.1% | 28.1% | 15.4% | 15.0% | |
| 3.8% | 0.2% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | 163.4% | 55.6% | 8.0% | 0.8% | 0.6% | – | – | – | 0.1% | – | 0.1% | 0.0% | – | |
| 68.6% | 6.1% | 15.3% | 5.7% | 4.3% | 4.9% | 12.5% | 3.1% | 9.0% | 38.2% | 4.5% | 6.4% | 11.0% | 12.1% | 13.0% | 29.1% | 6.1% | 3.0% | 4.5% | 11.4% | 5.0% | 3.5% | 8.9% | 14.1% | 7.2% | 6.6% | |
| 5.1% | 0.1% | 0.0% | 4.6% | 0.0% | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 22.3% | 92.4% | 115.1% | 43.0% | – | |
| 7.3% | 93.9% | 89.2% | 59.7% | 79.1% | 70.5% | 45.7% | 82.2% | 50.4% | 48.7% | -82.2% | -2.2% | -209.6% | -83.0% | 25.8% | 53.8% | 89.9% | 94.2% | 92.9% | 83.9% | 92.5% | 70.4% | -9.5% | -43.3% | -13.1% | 50.0% | |
| -467.6% | -51.6% | -133.6% | -64.6% | -61.1% | -184.2% | -431.2% | -490.3% | -1,616.8% | -12,123.8% | -1,815.7% | -1,969.4% | -4,674.1% | -6,204.2% | -4,674.3% | -10,945.3% | -2,878.2% | -427.3% | -571.9% | -1,018.2% | -516.1% | -800.8% | -754.3% | -816.1% | -488.8% | -327.3% | |
| 83.4% | 5.8% | 14.1% | 1.2% | 1.4% | 5.2% | 8.9% | 16.2% | 50.7% | 368.9% | 118.1% | 149.8% | 354.6% | 603.4% | 416.1% | 1,062.5% | 321.4% | 52.9% | 82.9% | 140.6% | 75.4% | 116.0% | 97.5% | 98.9% | 60.7% | 40.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.